Deep Brain Stimulation Surgery Makes a Giant Leap Forward presented by Dr. Bradley Wallace

Описание: Our program presenter is neurosurgeon Dr. Bradley Wallace, MD – who recently surgically implanted Medtronic’s new directional lead and Percept devices; Dr. Wallace will provide attendees his firsthand insight of what this latest technology brings to the forefront today, what this advancement means as far as value to the patient and the surgical process, and equally as exciting - what this technology means to near future advancements in DBS surgery.

Recent FDA approval of, and subsequent surgical implants of Medtronic’s new directional lead with SenseSight technology coupled with their pulse generator Percept used in Deep Brain Stimulation (DBS) surgery, has exponentially elevated the race for continued advancements in DBS surgery.

Available in some form for several years, in theory, the value of directional lead technology used in DBS surgery has primarily been that it allows surgeons more options to better “steer” the electrical impulses needed to stimulate specific parts of the brain and correspondingly reduce the potential for unwanted or undesirable side effects - occasionally caused by residual effects of the surgery itself.

All leads used in DBS surgery, whether or not they have directional capability, require a cohort implant of a pulse generator (essentially a battery) that is used to deliver the electrical impulses along the lead to stimulate the targeted area of the brain that is severely compromised with lack of dopamine production.

In addition to allowing more specific targeting of electrical impulses into the brain, Medtronic’s Percept along with their directional lead (with SenseSight technology) is where the greatest advancement of technology has emerged; Percept has the capability to not only deliver electrical impulses to the brain, but it also has the capability to receive electrical impulse feedback as well.

By receiving these electrical impulses back from the brain, Percept with the SenseSight technology collects downloadable data which can be used to identify patterns of when the patient’s brain requires stimulation, specifically where it needs the impulses sent, and in what increments.

With Medtronic’s foray into their new directional lead with SenseSight technology coupled with their Percept battery, they have truly opened the door to future advancements and potentially dramatically improved outcomes in DBS surgery.

This webinar was pre-recorded and presented by the Parkinson Association of Greater Daytona Beach. To learn more visit www.parkinsondaytona.org